Keywords:
Aerosol; anesthesia; nebulizer; pediatric; perioperative adverse events; salbutamol
Abstract:
Bronchospasm is a common respiratory adverse event in pediatric anesthesia. First-line treatment commonly includes inhaled salbutamol. This review focuses on the current best practice to deliver aerosolized medications to awake as well as anesthetized pediatric patients and discusses the advantages and disadvantages of various administration techniques.